Beijing Zhongjian Huayang gene technology research institute is the only business implementation unit of the international human gene variation group project (HVP) in China (approval No.: International HVP (2015) No. 003). It is the strategic cooperation
The strong R & D capability is the solid foundation for the sustainable development of China Health Alliance. The company invests a lot of money in laboratory research and development every year.